Tevogen Bio Holdings Inc.
TVGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $3 | $3 | $3 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $2 | $7 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $5 | $10 | $9 |
| Operating Income | -$6 | -$5 | -$10 | -$9 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$6 | -$6 | -$10 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$6 | -$10 | -$9 |
| % Margin | – | – | – | – |
| EPS | -0.03 | -0.031 | -0.065 | -0.052 |
| % Growth | 2% | 53% | -25.2% | – |
| EPS Diluted | -0.03 | -0.031 | -0.065 | -0.052 |
| Weighted Avg Shares Out | 196 | 184 | 161 | 178 |
| Weighted Avg Shares Out Dil | 196 | 184 | 161 | 178 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$5 | -$10 | -$9 |
| % Margin | – | – | – | – |